Asia Pacific Bioprocessing Facilities 2020

Asia Pacific Bioprocessing Facilities 2020

Featuring over 65 Bioprocessing Facilities from China, Taiwan, Korea, Japan, India, SEA, and Australia!
About Asia-Pacific Bioprocessing Facilities 2020

Asia-Pacific Bioprocessing Facilities 2020 covers  comprehensive information on parameters such as facility size, capacity, production technologies, types of biologics manufactured and much more. It provides readers a closer look into the facilities of Chugai, Hanmi, Daiichi Sankyo, Biocon (India & SEA), Beigene, Amgen (Singapore), GSK (Singapore) and more!

 

Key Takeaways
  • Insights on production processes various BioPharmas currently and plan to employ.
  • Understand the facility expansion plans of key players in the industry.
  • Identify potential clients who would be interested in your latest technology or service.
  • The report also features checklists based on DesignFlex30 and highlights examples of companies that have constructed their facilities in a flexible manner catering to the fast-changing needs of the industry.
Report Snapshot

Featured Companies

PURCHASE YOUR REPORT HERE!

For offline payments or inquiries, kindly contact Aisyah Atiqah at

e: aisyah.atiqah@imapac.com

t: +65 3109 0158

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users.

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

Section 1
• Preface
• Report Scope & Data Coverage
• IMAPAC’s Research Methodology

Section 2: Bioprocessing Facilities in Greater China
• Henlius Pharma
• Innovent Biologics
• Pfizer
• Tonhua Dongbao
• AlphaMab
• Akeso Pharmaceuticals
• Hanmi Pharma
• Sinovac
• BeiGene
• Junshi Biosciences
• Tot Biopharma
• Hualan Biological Engineering

Section 3: Bioprocessing Facilities In Korea And Japan
• Samsung Bioepis
• Astellas
• Celltrion
• Chugai
• Hanmi Pharma
• Kyowa Hakko Kirin
• Aprogen Biologiccs
• Daiichi Sankyo

Section 4: Bioprocessing Facilities In India And Australia
• Aurobindo
• CSL Bering
• Serum Institute of India
• CSIRO
• Enzene Biosciences
• Stelis Biopharma

Section 5: Bioprocessing Facilities In South-East-Asia
• Abbvie
• GSK
• AJ Biologics
• Amgen
• Novartis Thailand
• Baxter
• Takeda
• Siam Biosciences

Section 6: Region-Wise Data & Analysis Of Manufacturing Facility {Regions Covered: China, Taiwan, Japan& Korea, India, Australia & Sea}
• Products Manufactured: Vaccines| Cell Therapy| Recombinant Proteins & Mabs | Others
• Technologies Housed and Bioprocessing Processes
• Plant Capacity
• Projects In Pipeline
• Biomanufacturing Investment
• Regulatory Approvals
• Facility Size, Design
• Financial Insights
• Pestel Analysis

Section 7: Our Other Reports
• Bibiliography
• Disclaimer
• About Us
• Our Other Reports